Nymox Announces Positive Phase 3 Results In BPH Studies

Shares of tiny NYMX are up 103% after announcing positive phase 3 results in benign prostatic hyperplasia studies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.